101 related articles for article (PubMed ID: 21725619)
1. TCF3 inhibits F9 embryonal carcinoma growth by the down-regulation of Oct4.
Lin G; Zhao L; Yin F; Lan R; Li L; Zhang X; Zhang H; Yang B
Oncol Rep; 2011 Oct; 26(4):893-9. PubMed ID: 21725619
[TBL] [Abstract][Full Text] [Related]
2. Lidamycin induces neural differentiation of mouse embryonic carcinoma cells through down-regulation of transcription factor Oct4.
Zhen HY; He QH; Li Y; Zhou J; Yao C; Liu YN; Ma LJ
Biochem Biophys Res Commun; 2012 Apr; 421(1):44-50. PubMed ID: 22480685
[TBL] [Abstract][Full Text] [Related]
3. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells.
Lin Y; Yang Y; Li W; Chen Q; Li J; Pan X; Zhou L; Liu C; Chen C; He J; Cao H; Yao H; Zheng L; Xu X; Xia Z; Ren J; Xiao L; Li L; Shen B; Zhou H; Wang YJ
Mol Cell; 2012 Nov; 48(4):627-40. PubMed ID: 23041284
[TBL] [Abstract][Full Text] [Related]
6. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells.
Rosfjord E; Rizzino A
Biochem Biophys Res Commun; 1994 Sep; 203(3):1795-802. PubMed ID: 7945330
[TBL] [Abstract][Full Text] [Related]
7. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
Bahrami AR; Matin MM; Andrews PW
Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
[TBL] [Abstract][Full Text] [Related]
8. Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.
Dann CT; Alvarado AL; Molyneux LA; Denard BS; Garbers DL; Porteus MH
Stem Cells; 2008 Nov; 26(11):2928-37. PubMed ID: 18719224
[TBL] [Abstract][Full Text] [Related]
9. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells.
Soprano DR; Teets BW; Soprano KJ
Vitam Horm; 2007; 75():69-95. PubMed ID: 17368312
[TBL] [Abstract][Full Text] [Related]
10. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
11. The function of inducible promoter systems in F9 embryonal carcinoma cells.
Miller K; Rizzino A
Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
[TBL] [Abstract][Full Text] [Related]
12. SC1 inhibits the differentiation of F9 embryonic carcinoma cells induced by retinoic acid.
Liu Y; Ren X; Ke J; Zhang Y; Wei Q; Shi Z; Ai Z; Guo Z
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):793-799. PubMed ID: 29945210
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptors 1 and 2 are differentially regulated in murine embryonal carcinoma cells and in response to fibroblast growth factor-4.
Ali J; Mansukhani A; Basilico C
J Cell Physiol; 1995 Nov; 165(2):438-48. PubMed ID: 7593222
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
Pera MF; Bennett W; Cerretti DP
Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
[TBL] [Abstract][Full Text] [Related]
15. Isolation of human embryonal carcinoma stem cells by immunomagnetic sorting.
Przyborski SA
Stem Cells; 2001; 19(6):500-4. PubMed ID: 11713341
[TBL] [Abstract][Full Text] [Related]
16. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells.
Matin MM; Walsh JR; Gokhale PJ; Draper JS; Bahrami AR; Morton I; Moore HD; Andrews PW
Stem Cells; 2004; 22(5):659-68. PubMed ID: 15342930
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
18. Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3.
Slyper M; Shahar A; Bar-Ziv A; Granit RZ; Hamburger T; Maly B; Peretz T; Ben-Porath I
Cancer Res; 2012 Nov; 72(21):5613-24. PubMed ID: 23090119
[TBL] [Abstract][Full Text] [Related]
19. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene.
Lin H; Shabbir A; Molnar M; Lee T
Biochem Biophys Res Commun; 2007 Mar; 355(1):111-6. PubMed ID: 17280643
[TBL] [Abstract][Full Text] [Related]
20. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
